GENRYZON Trademark

Trademark Overview

On Thursday, August 20, 2015, a trademark application was filed for GENRYZON with the United States Patent and Trademark Office. The USPTO has given the GENRYZON trademark a serial number of 86730689. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 5, 2025. This trademark is owned by Pfizer Inc.. The GENRYZON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of endocrine diseases and disorders, namely, human growth hormones
genryzon

General Information

Serial Number86730689
Word MarkGENRYZON
Filing DateThursday, August 20, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 5, 2025
Registration Number5686466
Registration DateTuesday, February 26, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 8, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of endocrine diseases and disorders, namely, human growth hormones

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 5, 2025
Primary Code005
First Use Anywhere DateMonday, January 14, 2019
First Use In Commerce DateMonday, January 14, 2019

Trademark Owner History

Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Friday, October 30, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 24, 2015NEW APPLICATION ENTERED
Tuesday, August 25, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 30, 2015ASSIGNED TO EXAMINER
Wednesday, November 18, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 8, 2015PUBLISHED FOR OPPOSITION
Tuesday, December 8, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 2, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 14, 2016SOU TEAS EXTENSION RECEIVED
Thursday, July 14, 2016SOU EXTENSION 1 FILED
Thursday, July 14, 2016SOU EXTENSION 1 GRANTED
Saturday, July 16, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 15, 2016SOU TEAS EXTENSION RECEIVED
Thursday, December 15, 2016SOU EXTENSION 2 FILED
Thursday, December 15, 2016SOU EXTENSION 2 GRANTED
Saturday, December 17, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 21, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, June 21, 2017SOU EXTENSION 3 FILED
Wednesday, June 21, 2017SOU EXTENSION 3 GRANTED
Thursday, January 18, 2018SOU EXTENSION 4 GRANTED
Friday, June 23, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 18, 2018SOU TEAS EXTENSION RECEIVED
Thursday, January 18, 2018SOU EXTENSION 4 FILED
Saturday, January 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 22, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, May 22, 2018SOU EXTENSION 5 FILED
Wednesday, May 30, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 31, 2018SOU EXTENSION 5 GRANTED
Friday, June 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 22, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, January 22, 2019USE AMENDMENT FILED
Thursday, January 24, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, January 24, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, January 25, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 26, 2019REGISTERED-PRINCIPAL REGISTER
Monday, March 23, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, March 23, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 23, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 26, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 26, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 26, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 26, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, March 26, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 26, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 23, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 23, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 23, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 27, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Monday, March 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 26, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, September 5, 2025CANCELLED SEC. 8 (6-YR)
Monday, March 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

genryzon namely human growth hormones disorders diseases preparations treatment endocrine pharmaceutical